about
Tackling Unwanted Proteolysis in Plant Production Hosts Used for Molecular FarmingDevelopment of an optimized tetracycline-inducible expression system to increase the accumulation of interleukin-10 in tobacco BY-2 suspension cells.A membrane-bound matrix-metalloproteinase from Nicotiana tabacum cv. BY-2 is induced by bacterial pathogensPlant peroxisomes are degraded by starvation-induced and constitutive autophagy in tobacco BY-2 suspension-cultured cells.Molecular farming of pharmaceutical proteins using plant suspension cell and tissue cultures.Tobacco bZIP factor TGA10 is a novel member of the TGA family of transcription factors.Developments in the production of mucosal antibodies in plants.Inhibition of protease activity by antisense RNA improves recombinant protein production in Nicotiana tabacum cv. Bright Yellow 2 (BY-2) suspension cells.Monoclonal tobacco cell lines with enhanced recombinant protein yields can be generated from heterogeneous cell suspension cultures by flow sorting.Comprehensive characterization of two different Nicotiana tabacum cell lines leads to doubled GFP and HA protein production by media optimization.Variable nuclear cytoplasmic distribution of the 11.5-kDa zinc-binding protein (parathymosin-alpha) and identification of a bipartite nuclear localization signal.Over-expression of Trxo1 increases the viability of tobacco BY-2 cells under H2O2 treatment.Production of Desmodus rotundus salivary plasminogen activator alpha1 (DSPAalpha1) in tobacco is hampered by proteolysis.Tobacco bZIP transcription factor TGA2.2 and related factor TGA2.1 have distinct roles in plant defense responses and plant development.Biochemical properties of the matrix metalloproteinase NtMMP1 from Nicotiana tabacum cv. BY-2 suspension cells.Targeted gene exchange in plant cells mediated by a zinc finger nuclease double cut.Low Protease Content in Medicago truncatula Cell Cultures Facilitates Recombinant Protein Production.Production of an active recombinant thrombomodulin derivative in transgenic tobacco plants and suspension cells.Contained Molecular Farming Using Plant Cell and Tissue CulturesPlant Molecular Pharming, Pharmaceuticals for Human Health plant molecular pharming pharmaceuticals for human healthPlant Molecular Pharming, Pharmaceuticals for Human Health plant molecular pharming pharmaceuticals for human healthPharmaceuticalsProduction of Pharmaceutical Proteins in Plants and Plant Cell Suspension CulturesOptimizing product quality in molecular farmingTargeted insertion of large DNA sequences by homology-directed repair or non-homologous end joining in engineered tobacco BY-2 cells using designed zinc finger nucleasesGenome Editing in Agriculture: Technical and Practical Considerations
P50
Q26750988-7E33D332-95AA-4135-A117-1DF834FD923BQ30425644-1F958AA9-19C0-4A61-8A4F-BD23A944075BQ33475973-E20BB98D-B897-402C-A196-8209D79A7706Q34530842-CE408FE1-2013-4BA7-8DCF-08E28AF9792FQ38080185-9265A459-D96E-4B06-9BFA-2236EAD2F201Q38354111-A88B34C5-78CB-46E6-B900-353DEA23151BQ38655520-8A169A75-A815-4674-9CE5-323EEF403AF5Q38995002-A1946CF8-8C8D-4B25-9A8D-C2E4BCE14BA7Q39320649-8A86F65C-EC6E-4C5A-BF92-E45715677ADDQ39447813-916BBBDB-2042-48C0-9FA9-A3B6DD773F65Q41239785-A2725F39-CC95-43D1-ADBE-D49B2F0E0FCAQ41976122-F35F26AA-9E64-41B6-9B71-30B4E966C070Q45247286-9BEE83B0-540A-4EB8-BD81-8075C97F5917Q46707358-82785F4D-0712-448B-AA1C-D2C9F1CB5ED2Q47837672-C22A4B35-60EE-4750-BC8F-9FBA520395C6Q48125758-1F919660-9A24-4CED-BF6B-B8C06910192BQ51148183-D11DC321-6939-4CA6-9D6B-6118F263C81FQ51814110-DF93D393-C2A9-4C56-97AD-34DF21C1DDF9Q57694977-240520B9-0129-4737-8D4A-CEF781FFA330Q57694986-7333DB22-F7B3-4006-A30B-906F71047CFFQ57694990-1A26E01E-EF93-44BE-B9F2-0DCB628A1801Q57694992-7ED03E10-B93A-43A8-92F4-B8EBAF230532Q57694995-2CF126AA-FCF6-4D40-AD24-A0A8DA6BDA01Q90591123-C2DBDE82-1AFA-4E5F-BA39-411137BED034Q92281598-8FC0D100-8260-43B3-BBF0-2D62226266B0Q92755908-B3C6BCB2-4336-48ED-8700-6FDB693DD32C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Andreas Schiermeyer
@ast
Andreas Schiermeyer
@en
Andreas Schiermeyer
@es
Andreas Schiermeyer
@nl
type
label
Andreas Schiermeyer
@ast
Andreas Schiermeyer
@en
Andreas Schiermeyer
@es
Andreas Schiermeyer
@nl
prefLabel
Andreas Schiermeyer
@ast
Andreas Schiermeyer
@en
Andreas Schiermeyer
@es
Andreas Schiermeyer
@nl
P214
P1053
I-2125-2013
P106
P1153
6507750495
P1960
atiinUAAAAAJ
P2002
P214
P2798
P31
P3829
P3835
andreas-schiermeyer
P496
0000-0002-2057-4111
P734
P735
P7859
viaf-47672856